<unk>  is an antiparkinsonian, autonomic, central nervous system agent, dopamine agonist that is FDA approved for the treatment of Parkinson's disease as an adjunctive treatment with carbidopa/levodopa. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include dyskinesia, hallucinations, somnolence, insomnia, nausea, constipation, diarrhea, dyspepsia and rhinitis.
Pergolide
Vintafolide
Quinagolide
Flunisolide 
Olaflur
Halcinonide
Eliglustat
Flurandrenolide